Pharmafile Logo
Pharmafocus logo
Advanced Search

Sandoz opens biosimilar development centre in Slovenia

June 19, 2026
Business Development Sandoz, biosimilar development

Sandoz has opened a new biosimilar development centre in Ljubljana, Slovenia, as part of efforts to expand its in-house capabilities …

News

Codis announces three senior business development appointments

June 18, 2026
Codis

Codis has announced three strategic appointments within its Business Development function. Pedro Fernandes Botas has been appointed as Business Development …

Appointment

US laboratory approval supports launch of lung cancer blood test

June 17, 2026
lung cancer blood test

UK based Cizzle Biotechnology has announced that its CIZ1B lung cancer blood test has been approved for use under Clinical …

News

Study to examine ways of improving diabetes care for younger adults

June 16, 2026
diabetes

Researchers at Northumbria University are leading a £1.3m study aimed at helping GP practices improve care for young adults living …

News

Phase 2 endometriosis trial reaches recruitment milestone

June 15, 2026
Research and Development Gesynta Pharma, endometriosis

Gesynta Pharma has announced that 50% of the target enrolment has been reached in its phase 2 NOVA trial evaluating …

News

NICE backs atogepant for acute migraine treatment

June 12, 2026
NICE, atogepant, migraine treatment

NICE has issued Final Draft Guidance recommending AbbVie’s AQUIPTA (atogepant) as an option for the acute treatment of migraine, with …

News

Survey data highlight challenges in anaphylaxis treatment adherence

June 11, 2026
European Academy of Allergy and Clinical Immunology (EAACI), anaphylaxis

New survey data presented at the European Academy of Allergy and Clinical Immunology (EAACI) Congress suggest many people at risk …

News

Hansa Biopharma appoints Fredrik Röök as VP Business Development

June 11, 2026
Business Development Hansa Biopharma

Hansa Biopharma has announced that Fredrik Röök has been appointed as VP Business Development, as of 17 August. Röök will …

Appointment

Sofinnova and AWS collaborate on AI tools for life sciences

June 10, 2026
Research and Development AI, Amazon Web Services (AWS), Sofinnova

Sofinnova Partners has announced a collaboration with Amazon Web Services (AWS) aimed at expanding the use of AI across life …

News

First European approval given to non-opioid treatment for chronic low back pain

June 9, 2026
Research and Development low back pain, non-opioid treatment

Germany has granted marketing authorisation to Exilby (VER-01) for the treatment of chronic low back pain with a neuropathic component, …

News

Closing the immunisation gap: partnership working that delivered at scale

June 5, 2026
Business Services, Market Access Consultancy Visions4Health

As the UK healthcare system navigates a period of significant change, the path to successful market access is becoming increasingly …

Feature
Thought Leadership

Phase 2 study explores imaging approach for interstitial lung disease

June 5, 2026
Research and Development interstitial lung disease

Serac Healthcare has presented phase 2 data suggesting its investigational imaging agent, 99mTc-maraciclatide, may help distinguish active inflammation from fibrosis …

News

Laverock secures funding for gene-control platform development

June 4, 2026
Research and Development Laverock Therapeutics

Laverock Therapeutics has been awarded more than £2.2m in grant funding to support development of its gene-control platform and expand …

News

LifeArc and Elpida partner to advance gene therapies for ultra-rare childhood diseases

June 3, 2026
Research and Development gene therapies

LifeArc has announced a partnership with Elpida Therapeutics to support development of gene therapies for three ultra-rare neurodegenerative diseases affecting …

News

Well Pharmacy and Alzheimer’s Society launch dementia partnership

June 2, 2026
Research and Development dementia

Well Pharmacy has announced a partnership with Alzheimer’s Society aimed at improving support for people living with dementia and their …

News

China approves fruquintinib combination for kidney cancer

May 29, 2026
Kidney cancer, Nephrology

China’s National Medical Products Administration (NMPA) has approved a combination of ELUNATE (fruquintinib) and TYVYT (sintilimab) for patients with advanced …

News

BIOTRONIK, Charité and GHCF launch digital cardiology partnership

May 28, 2026
Biotronik, Cardiology

BIOTRONIK, Charité – Universitätsmedizin Berlin and the German Heart Center Foundation (GHCF) have announced a partnership focused on advancing digital …

News

Endometriosis study begins recruitment in UK hospitals

May 28, 2026
Clinical Research, Recruitment Cyclana Bio, endometriosis

Cyclana Bio has recruited the first patients into a 500-participant observational study investigating the biological mechanisms behind endometriosis, following approval …

News
drug-trials

MHRA authorises donidalorsen for hereditary angioedema prevention

May 27, 2026
Research and Development donidalorsen

Otsuka Pharmaceuticals UK announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has authorised Dawnzera (donidalorsen) for routine prevention …

News

Partnership aims to expand early access to medicines

May 26, 2026
Maprium, The Medicine Access Channel

Maprium and The Medicine Access Channel have announced a partnership intended to support earlier patient access to medicines that have …

News

SMC accepts amivantamab and lazertinib for EGFR-positive lung cancer

May 22, 2026
SMC, amivantamab, lazertinib, lung cancer

The Scottish Medicines Consortium (SMC) has accepted Rybrevant (amivantamab) in combination with Lazcluze (lazertinib) for use within NHS Scotland as …

News
The Gateway to Local Adoption Series

Latest content

Sandoz opens biosimilar development centre in Slovenia

June 19, 2026

Codis announces three senior business development appointments

June 18, 2026

US laboratory approval supports launch of lung cancer blood test

June 17, 2026

Study to examine ways of improving diabetes care for younger adults

June 16, 2026

Phase 2 endometriosis trial reaches recruitment milestone

June 15, 2026